Mark Larché

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Infectious Diseases

Allergic Rhinitis

Peripheral Blood

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Oliver Pfaar, Jean Bousquet, Stephen R Durham, Jörg Kleine Tebbe, Mark Larché, Graham C Roberts, M H Mohamed Shamji, Roy Gerth van Wijk
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence. Allergy (2021)
Oliver Pfaar, Karl-Christian Bergmann, Sergio Bonini, Enrico Compalati, Nathalie Domis, Fréderic de Blay, Pieter-Jan de Kam, Philippe Devillier, Stephen R Durham, Anne K Ellis, Alina Gherasim, Laura Haya, Jens M Hohlfeld, Friedrich Horak, Tomohisa Iinuma, Robert L Jacobs, Henrik Hugo Jacobi, Marek Jutel, Susanne Kaul, Suzanne Marie Kelly, Ludger Klimek, Mark Larché, Patrick Lemell, Vera Mahler, Hendrik Nolte, Yoshitaka Okamoto, Piyush Patel, Ronald L Rabin, Cynthia Rather, Angelika Sager, Anne Marie Salapatek, Torben Sigsgaard, Alkis Togias, Christoph Willers, William H Yang, René Zieglmayer, Torsten Zuberbier, Petra Zieglmayer
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report. Allergy 76 (12) (2021)
Mark Larché
Obituary: Anthony Barrington Kay (1939-2020). Allergy 76 (3) (2021)
Varun Muddaluru, Rudolph Valenta, Susanne Vrtala, Thomas Schlederer, James Hindley, Pascal Hickey, Mark Larché, Elena Tonti
Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA. Allergy 76 (7) (2021)
Young Woong Kim, Elena Tonti, Pascal Hickey, Anne K Ellis, Helen Neighbour, Mark Larché, Scott J Tebbutt
Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre- and post-peptide immunotherapy: An open-label clinical study. Allergy 76 (6) (2020)
Christopher D Rudulier, Elena Tonti, Eddie James, William Wai-Hung Kwok, Mark Larché
Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy. Allergy 74 (11) (2019)
Mark Larché
Legends of allergy/immunology: A. Barry Kay. Allergy 74 (8) (2019)